Johns Hopkins researcher Matthew Johnson discusses the future for psychedelics research in light of Oregon's measure to legalize psilocybin for clinical use
Researchers rely on this carefully selected classical and contemporary music playlist to enhance the psychedelic experience for their patients during psilocybin studies
The antidepressant effect of the psilocybin—the active compound in so-called magic mushrooms—was about four times greater than is typically seen in traditional antidepressants currently on the market
Johns Hopkins researchers discover that people who had previously identified as atheists described encountering a "benevolent entity" upon inhaling the psychedelic DMT
/ Johns Hopkins Magazine
The center, believed to be the first and largest of its kind, will use psychedelics to study the mind, identify therapies for diseases such as addiction, PTSD, Alzheimer's
Psychoactive mushrooms may help individuals with depression and anxiety, but each trip can last from four to six hours. Enter the toad.
/ Johns Hopkins Magazine
Majority of people who have reported encountering 'God'—whether spontaneously or triggered by psychedelics—report lasting positive changes to psychological health
In mouse study, MDMA is shown to reactivate a learning period for social rewards, allowing test subjects to form positive associations where none existed before
Study finds that humans and octopuses have a molecular mechanism in the brain that binds to MDMA—revealing evolutionary links between the two species
/ Johns Hopkins Magazine